Author

Quentin GOOR

InsermPrimary ORCID profile (0009-0006-4035-0795 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Quentin GooriD1 paper · Institut de Biologie Structurale

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:plant (other)· 1 Approach:statistical model· 1 Assay:structural biology· 1

Frequent Co-Authors

Ahmed HaouziD· 1 shared Anaïs MerckxiD· 1 shared Ariel MéchalyiD· 1 shared Benjamin BardiauxiD· 1 shared Blandine Séon‐Méniel· 1 shared Bruno FigadèreiD· 1 shared Célia Caillet‐SaguyiD· 1 shared Didier DesmaëleiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Ahmed HaouzORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis derived fungal metabolite targeting Pyruvate Kinase II

Lucille Hervé, Nadia Amanzougaghene, Séverine Amand, Magali Blaud, Romain Coppée, Zaineb Fourati, Jean‐François Franetich, Quentin GOOR, Sandrine Houzé, Murielle Lohezic, Mathilde Patat, Véronique Sarrasin, Emilie Zélie, Valérie Soulard, Stéphane Mann, Anaïs Merckx

This study identifies skeletocutin E as a dual-stage antimalarial compound that inhibits Plasmodium falciparum pyruvate kinase II, showing efficacy against both blood and liver stages of the parasite.

bioRxiv · Mar 18, 2026 · PreprintMicrobiology

HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2

Flavio Alvarez, Florence Larrous, Ariel Méchaly, Benjamin Bardiaux, Quentin GOOR, Ahmed Haouz, Blandine Séon‐Méniel, Rodolphe Alves de Sousa, Stéphane Bourg, Didier Desmaële, Bruno Figadère, Nicolas Wolff, Hélène Munier‐Lehmann, Célia Caillet‐Saguy

This paper identifies small molecules that inhibit the SARS-CoV-2 E protein interaction with ZO-1 PDZ2 using X-ray crystallography, HTRF screening, and docking simulations, with one compound showing antiviral activity.

Scientific Reports · Dec 28, 2025Peer-reviewedBiochemistry